{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:29:09Z","timestamp":1792682949504,"version":"4.5.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Linear growth during childhood is the result of the synergic contribution of different factors. The best growth determinant system during each period of life is represented by the growth hormone\u2013insulin-like growth factor axis (GH\u2013IGF), even if several other factors are involved in normal growth. Within the broad spectrum of growth disorders, an increased importance has been placed on growth hormone insensitivity (GHI). GHI was reported for the first time by Laron as a syndrome characterized by short stature due to GH receptor (GHR) mutation. To date, it is recognized that GHI represents a wide diagnostic category, including a broad spectrum of defects. The peculiar characteristic of GHI is the low IGF-1 levels associated with normal or elevated GH levels and the lack of IGF-1 response after GH administration. Recombinant IGF-1 preparations may be used in the treatment of these patients.<\/jats:p>","DOI":"10.3389\/fendo.2023.1141039","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T01:34:51Z","timestamp":1678844091000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Short stature related to Growth Hormone Insensitivity (GHI) in childhood"],"prefix":"10.3389","volume":"14","author":[{"given":"Concetta","family":"Mastromauro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000001033","article-title":"Genetic evaluation in children with short stature","volume":"33","author":"Zhou","year":"2021","journal-title":"Curr Opin Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198910123211501","article-title":"Laron dwarfism and mutations of the growth hormone-receptor gene","volume":"321","author":"Amselem","year":"1989","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2011.00095","article-title":"Genetic defects in the growth hormone-IGF-I axis causing growth hormone insensitivity and impaired linear growth","volume":"2","author":"Savage","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502231","article-title":"Diagnosis, genetics, and therapy of short stature in children: A growth hormone research society international perspective","volume":"92","author":"Collett-Solberg","year":"2019","journal-title":"Hormone Res paediatrics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/adc.31.159.372","article-title":"Aberdeen Growth study. i. the prediction of adult body measurements from measurements taken each year from birth to 5 years","volume":"31","author":"Healy","year":"1956","journal-title":"Arch Dis childhood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4946.20.05835-1","article-title":"A new approach to the diagnosis of short stature","volume":"72","author":"Bogar\u00edn","year":"2020","journal-title":"Minerva pediatrica"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.63.1.141","article-title":"Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles","volume":"63","author":"Butler","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031418","article-title":"Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction","volume":"89","author":"Milward","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2006.08.003","article-title":"The growth hormone receptor in growth","volume":"36","author":"Bougn\u00e8res","year":"2007","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/eje.1.01797","article-title":"Genetic control of growth","volume":"152","author":"Mullis","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B11","article-title":"A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro","volume":"49","author":"Salmon","year":"1957","journal-title":"J Lab Clin Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-0436.1985.tb00316.x","article-title":"A dual effector theory of growth-hormone action","volume":"29","author":"Green","year":"1985","journal-title":"Differentiation; Res Biol Diversity"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.7079756","article-title":"Growth hormone stimulates longitudinal bone growth directly","volume":"216","author":"Isaksson","year":"1982","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"E167","DOI":"10.1152\/ajpendo.00416.2016","article-title":"Cholestyramine treatment of healthy humans rapidly induces transient hypertriglyceridemia when treatment is initiated","volume":"313","author":"Sj\u00f6berg","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40618-015-0327-2","article-title":"Growth hormone insensitivity: diagnostic and therapeutic approaches","volume":"39","author":"Kurto\u011flu","year":"2016","journal-title":"J endocrinol Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1506","article-title":"Genetic evaluation of short stature","volume":"99","author":"Dauber","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00129785-200202020-00003","article-title":"Genetic characterization of growth hormone deficiency and resistance: implications for treatment with recombinant growth hormone","volume":"2","author":"Baumann","year":"2002","journal-title":"Am J pharmacogenomics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1330654","article-title":"Growth hormone receptor: structure and signal transduction","volume":"133","author":"Postel-Vinay","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.151s011","article-title":"New molecular mechanisms of GH resistance","author":"Rosenfeld","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000744","article-title":"Structure and function of the type 1 insulin-like growth factor receptor","volume":"57","author":"Adams","year":"2000","journal-title":"Cell Mol Life sciences: CMLS"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20141293","article-title":"JAK2 activation by growth hormone and other cytokines","volume":"466","author":"Waters","year":"2015","journal-title":"Biochem J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/ijms19051433","article-title":"Growth hormone receptor mutations related to individual dwarfism","volume":"19","author":"Lin","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13210","article-title":"Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature","volume":"21","author":"Dias","year":"2017","journal-title":"J Cell Mol Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70121-6","article-title":"Growth hormone insensitivity: physiologic and genetic basis, phenotype, and treatment","volume":"135","author":"Rosenbloom","year":"1999","journal-title":"J Pediatr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(98)00062-9","article-title":"The broad spectrum of inherited growth hormone insensitivity syndrome","volume":"9","author":"Johnston","year":"1998","journal-title":"Trends Endocrinol metabolism: TEM"},{"key":"B26","article-title":"Genetic pituitary dwarfism with high serum concentation of growth hormone\u2013a new inborn error of metabolism","volume":"2","author":"Laron","year":"1966","journal-title":"Israel J Med Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ghir.2017.12.004","article-title":"Genetic disorders of GH action pathway","volume":"38","author":"Domen\u00e9","year":"2018","journal-title":"Growth hormone IGF Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/js.2016-1119","article-title":"Novel dominant-negative GH receptor mutations expands the spectrum of GHI and IGF-I deficiency","volume":"1","author":"Vairamani","year":"2017","journal-title":"J Endocrine Soc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2005.04.009","article-title":"Diagnostic and therapeutic advances in growth hormone insensitivity","volume":"34","author":"David","year":"2005","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.20.8083","article-title":"Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with laron-type dwarfism","volume":"86","author":"Godowski","year":"1989","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1500635","article-title":"Primary GH insensitivity \u2018(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I","volume":"150","author":"Besson","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-020-09595-0","article-title":"Laron syndrome - a historical perspective","volume":"22","author":"Laron","year":"2021","journal-title":"Rev endocrine Metab Disord"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4158\/EP15939.RA","article-title":"LESSONS FROM 50 YEARS OF STUDY OF LARON SYNDROME","volume":"21","author":"Laron","year":"2015","journal-title":"Endocrine Pract"},{"key":"B34","article-title":"Penis and testicular size in patients with growth hormone insufficency","volume":"63","author":"Laron","year":"1970","journal-title":"Acta endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11154-020-09602-4","article-title":"Insights from the clinical phenotype of subjects with laron syndrome in Ecuador","volume":"22","author":"Guevara-Aguirre","year":"2021","journal-title":"Rev endocrine Metab Disord"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02558.x","article-title":"Body composition in untreated adult patients with laron syndrome (primary GH insensitivity)","volume":"65","author":"Laron","year":"2006","journal-title":"Clin Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000183762","article-title":"Body fat in laron syndrome patients: effect of insulin-like growth factor I treatment","volume":"40","author":"Laron","year":"1993","journal-title":"Hormone Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8229","article-title":"Leptin concentrations in GH deficiency: the effect of GH insensitivity","volume":"87","author":"Marzullo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2008.03.003","article-title":"Nonalcoholic fatty liver in patients with laron syndrome and GH gene deletion - preliminary report","volume":"18","author":"Laron","year":"2008","journal-title":"Growth hormone IGF Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06392.x","article-title":"A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization","volume":"13","author":"Duquesnoy","year":"1994","journal-title":"EMBO J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2015.08.003","article-title":"The origin of the p.E180 growth hormone receptor gene mutation","volume":"28","author":"Ostrer","year":"2016","journal-title":"Growth hormone IGF Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36444","article-title":"The E180splice mutation in the GHR gene causing laron syndrome: witness of a Sephardic Jewish exodus from the Iberian peninsula to the new world","author":"Gon\u00e7alves","year":"2014","journal-title":"Am J Med Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2012.1048","article-title":"A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I","volume":"30","author":"Kang","year":"2012","journal-title":"Int J Mol Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.2.4601","article-title":"Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain","volume":"83","author":"Iida","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2624","article-title":"Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states","volume":"92","author":"Fang","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1086\/323266","article-title":"Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity","volume":"69","author":"Metherell","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06252","article-title":"A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signaling","volume":"188","author":"Maamra","year":"2006","journal-title":"J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1527","article-title":"An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes","volume":"92","author":"David","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.78.OC4.3","article-title":"Growth hormone receptor (GHR) 6\u03a9 pseudoexon activation: a novel cause of severe growth hormone insensitivity","volume":"107","author":"Cottrell","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000341739","article-title":"Spectrum of insulin-like growth factor deficiency","volume":"23","author":"Wit","year":"2012","journal-title":"Endocrine Dev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.016","article-title":"Inborn errors of human JAKs and STATs","volume":"36","author":"Casanova","year":"2012","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11154-020-09603-3","article-title":"Genetic causes of growth hormone insensitivity beyond GHR","volume":"22","author":"Hwa","year":"2021","journal-title":"Rev endocrine Metab Disord"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.14.7239","article-title":"Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression","volume":"94","author":"Udy","year":"1997","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2007.03.004","article-title":"Defects in growth hormone receptor signaling","volume":"18","author":"Rosenfeld","year":"2007","journal-title":"Trends Endocrinol metabolism: TEM"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N Engl J Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310495200","article-title":"Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b","volume":"279","author":"Hwa","year":"2004","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2882","article-title":"Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation","volume":"118","author":"Bernasconi","year":"2006","journal-title":"Pediatrics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0272","article-title":"A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings","volume":"163","author":"Pugliese-Pires","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203526","article-title":"The role of STAT proteins in growth hormone signaling","volume":"19","author":"Herrington","year":"2000","journal-title":"Oncogene"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00324.2014","article-title":"Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression","volume":"307","author":"Varco-Merth","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.1.407-419.2004","article-title":"Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation","volume":"24","author":"Shen","year":"2004","journal-title":"Mol Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"110979","DOI":"10.1016\/j.mce.2020.110979","article-title":"Activating mutations of STAT3: Impact on human growth","volume":"518","author":"Guti\u00e9rrez","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"108316","DOI":"10.1016\/j.clim.2019.108316","article-title":"Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunity","volume":"210","author":"J\u00e4gle","year":"2020","journal-title":"Clin Immunol (Orlando Fla.)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","author":"Woods","year":"1996","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.40.12.913","article-title":"A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency","volume":"40","author":"Bonapace","year":"2003","journal-title":"J Med Genet"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0452","article-title":"Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development","volume":"94","author":"Netchine","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","article-title":"Diagnosis and management of disorders of IGF-I synthesis and action","author":"Wit","year":"2011","journal-title":"Pediatr Endocrinol reviews: PER"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/edrv-16-1-3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocrine Rev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013100","article-title":"Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene","volume":"350","author":"Domen\u00e9","year":"2004","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2019.2018.0301","article-title":"A novel homozygous mutation of the acid-labile subunit (IGFALS) gene in a Male adolescent","volume":"11","author":"Poyrazo\u011flu","year":"2019","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20660","article-title":"The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity","volume":"113","author":"Clemmons","year":"2004","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0999","article-title":"Clinical and biochemical characteristics and bone mineral density of homozygous, compound heterozygous and heterozygous carriers of three novel IGFALS mutations","volume":"176","author":"I\u015f\u0131k","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1159\/000358329","article-title":"A novel homozygous mutation of the IGFALS gene in a female adolescent: indirect evidence for a contributing role of the circulating IGF-I pool in the pubertal growth spurt","volume":"81","author":"Poukoulidou","year":"2014","journal-title":"Hormone Res paediatrics"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1159\/000098479","article-title":"Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency","volume":"67","author":"Domen\u00e9","year":"2007","journal-title":"Hormone Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0303-7207(87)90093-1","article-title":"Insulin-like growth factor-I augments gonadotropin-stimulated androgen biosynthesis by cultured rat testicular cells","volume":"52","author":"Kasson","year":"1987","journal-title":"Mol Cell Endocrinol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1177\/039463200401700105","article-title":"Growth hormone antibodies formation in patients treated with recombinant human growth hormone","volume":"17","author":"Ahangari","year":"2004","journal-title":"Int J immunopathol Pharmacol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00985.x","article-title":"Five-year follow-up of growth hormone antibodies in growth hormone deficient children treated with recombinant human growth hormone","volume":"38","author":"Massa","year":"1993","journal-title":"Clin Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1089\/02724570050031239","article-title":"Monoclonal antibody against human growth hormone receptor","volume":"19","author":"Lattuada","year":"2000","journal-title":"Hybridoma"},{"key":"B81","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mce.2014.04.004","article-title":"Differential intracellular signalling properties of the growth hormone receptor induced by the activation of an anti-GHR antibody","volume":"390","author":"Lan","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3476(75)80706-2","article-title":"Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur","volume":"86","author":"Alagille","year":"1975","journal-title":"J Pediatr"},{"key":"B83","first-page":"54","article-title":"Evaluation of growth disorders in the paediatric clinic","volume":"26","author":"Cappa","year":"2003","journal-title":"J endocrinol Invest"},{"key":"B84","article-title":"Mauriac syndrome: growth failure and type 1 diabetes mellitus","author":"Kim","year":"2008","journal-title":"Pediatr Endocrinol reviews: PER"},{"key":"B85","doi-asserted-by":"publisher","first-page":"101318","DOI":"10.1016\/j.ghir.2020.101318","article-title":"A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I)","volume":"52","author":"Bright","year":"2020","journal-title":"Growth hormone IGF Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2016.01.002","article-title":"Past, present and future","volume":"28","author":"Bright","year":"2016","journal-title":"Growth hormone IGF Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-008-0124-9","article-title":"Recombinant human insulin-like growth factor-I therapy for children with growth disorders","volume":"25","author":"Richmond","year":"2008","journal-title":"Adv Ther"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1141039\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T01:34:58Z","timestamp":1678844098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1141039\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":87,"alternative-id":["10.3389\/fendo.2023.1141039"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1141039","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"article-number":"1141039"}}